Magnetic Resonance Imaging (MRI) can be used to inform treatment decisions for acute ischemic stroke patients, particularly when assessing eligibility of late-window patients for thrombolysis and thrombectomy.
Brainomix 360 e-MRI is an FDA-cleared visualization and processing tool which provides both analysis and viewing capabilities for Diffusion Weighted Imaging (DWI) and Dynamic Susceptibility Contrast (DSC) perfusion, allowing for side-by-side viewing of different MR sequences along with results.